Ovarian Cancer. December 2 3, The 9th International Conference on

Transcription

1 The 9th International Conference on Ovarian Cancer December 2 3, 2011 The University of Texas Cancer Center 8th Floor Conference Center Cancer Prevention Building 1155 Pressler, Houston, Texas

2 The 9th International Conference on Ovarian Cancer December 2 3, 2011 The University of Texas Cancer Center 8th Floor Conference Center, Cancer Prevention Building 1155 Pressler, Houston, Texas Abstract Submission Deadline: September 1, 2011 Abstract Submission Address: ovarianconf@mdanderson.org Goal The goal of this conference is to bring together oncologists, gynecologists, general practitioners, and allied health providers to present and discuss the most current information on the treatment of ovarian cancer. Participants from all over the world will be able to exchange professional information and network with others in the field. The conference will include new methods for detecting and diagnosing ovarian cancer, recent advances in basic and translational research, and discussions of contemporary and innovative treatments for ovarian cancer. Target Audience This program should be of interest to gynecologic oncologists, medical oncologists, OB-Gyns, genetic counselors, scientists/ researchers, nurses, nurse practitioners, and physician assistants. Educational Methods Lectures, Panel Discussions, Question-and-Answer Sessions, Case Studies, Poster Session Educational Objectives At the conclusion of this educational activity, participants should be able to practice appropriate screening for ovarian cancer (knowledge, competence, performance, patient outcomes); incorporate contemporary and innovative treatments for ovarian cancer (knowledge, competence, performance, patient outcomes); interpret basic and translational research for ovarian cancer (knowledge, competence, performance, patient outcomes). Evaluation A course evaluation form will provide participants with the opportunity to comment on the value of the program content related to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics. Accreditation/Credit Designation The University of Texas Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas Cancer Center designates this live activity for a maximum of AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurses Nursing continuing education contact hours will be provided. The University of Texas Cancer Center is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center s Commission on Accreditation. CME Certificates and Attendance Verification Certificates Certificates awarding AMA PRA Category 1 Credit TM or certificates documenting attendance will be distributed to participants as they depart the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form. Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

3 Call for Abstracts and Surgical Films Abstracts and surgical films may be submitted for presentation. The conference executive committee will select four abstracts and/or surgical films for oral presentation at the conference. Additional abstracts will be accepted for poster presentation and surgical films for video presentation. The deadline for submission of abstracts and surgical films is September 1, Abstract and Surgical Film Submission Guidelines 1. Submission of an abstract or surgical film constitutes a commitment by the author(s) to present it if accepted. 2. All submissions must be in English. 3. The abstract or surgical film must have a title that indicates the nature of the investigation. Capitalize each word in the title except for terms that usually appear lowercase, such as prefixes to chemical names. 4. Do not use abbreviations in the title of the abstract or surgical film. Standard abbreviations may be used without definition in the text. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word or phrase abbreviated. 5. Author names should be written in full. Please include the primary degree for each author (for example, MD, PhD). 6. Omit any reference to your institution in the abstract or surgical film to ensure proper-blinded review. 7. Use generic drug names and International Systems Units. Trade names should not be used. 8. Expenses associated with the submission and presentation of an abstract or surgical film are the responsibility of the presenter. Abstract Submission Regulations 1. The character limit for the abstract is 2,500 including spaces. However, this limit does not include the Abstract Title or Author String. 2. Each Abstract Submission must clearly identify the following: Objectives: an introductory sentence indicating the purpose of the study Methods: a brief description of pertinent experimental procedures, including statistical evaluation where appropriate Results: a summary of the new unpublished data Conclusions: a statement of the conclusions 3. the completed abstract to: ovarianconf@mdanderson.org 4. Abstracts will not be edited; however, the formatting will be altered to replicate that of the conference program where it will be published. 5. Freestanding 4 ft. x 8 ft. display boards and pushpins will be provided for the poster session. Surgical Film Submission Regulations 1. All films must meet the following requirements: Films cannot exceed 10 minutes in duration. Films must include sound. Films must be at regular speed. Films must be in.avi,.mpeg (.mpg) or.wmv format. Films must be uploaded to the submission site for consideration. The maximum file size available for upload is 200 MB. Please submit your film online at 2. Commercial support for the development of the film may be acknowledged by a single credit line, but specific products may not be endorsed in the film. Program Thursday, December 1, 2011 Hotel Zaza 6:00 pm Welcome Reception Friday, December 2, 2011 Cancer Prevention Building 8th Floor Conference Center 7:00 am Registration and Breakfast 8:15 Welcome David M. Gershenson, MD; and Richard R. Barakat, MD SESSION I: OVARIAN CANCER SCREENING Moderator: Stan Kaye, MD 8:30 Screening for Ovarian Cancer in the General Population Karen H. Lu, MD 9:00 Hereditary Ovarian Cancer Noah D. Kauff, MD 9:30 Genetic Counseling and Testing Molly S. Daniels, MS 10:00 Break SESSION II: RARE OVARIAN TUMORS Moderator: Jubilee Brown, MD 10:30 Rare Ovarian Tumors David Huntsman, MD 11:00 Low-grade Serous Ovarian Cancer David M. Gershenson, MD 11:30 Mucinous Ovarian Cancer Michael Frumovitz, MD, MPH

4 Noon Lunch (provided) SESSION III: SURGERY DEBATES Moderator: Robert L. Coleman, MD 1:00 pm Neoadjuvant Chemotherapy vs. Primary Surgical Cytoreduction Chemotherapy: Ignace Vergote, MD Surgery: Dennis S. Chi, MD 1:45 Secondary Surgical Cytoreduction Pro: Nadeem Abu-Rustum, MD Con: Pedro T. Ramirez, MD 2:30 Break SESSION IV: IMAGING AND QUALITY OF LIFE Moderator: Lois M. Ramondetta, MD 3:00 Novel Imaging for Ovarian Cancer Homer A. Macapinlac, MD 3:30 Palliative Care for Ovarian Cancer Patients Eduardo Bruera, MD 4:00 Ovarian Cancer Survivors Teaching Medical Students Nicki L. Flowers, RN, MS, WHNP 4:30 pm Adjourn Tour of 7:00 pm Conference Dinner Houston Museum of Natural Science PLANNING COMMITTEE Katherine M. Bell-McGuinn, MD, PhD Assistant Attending Medical Oncologist Gynecology Service, Department of Medicine, Memorial Sloan-Kettering Robert L. Coleman, MD, Nicki L. Flowers, RN, MS, WHNP Advanced Practice Nurse Ginger J. Gardner, MD Program Co-Chair Assistant Attending Surgeon Gynecology Service Department of Surgery Memorial Sloan-Kettering Patricia Heitz, BS, RN, OCN Nursing Education Specialist Nursing Extramural Programs Pedro T. Ramirez, MD Kathleen M. Schmeler, MD Program Co-Chair Assistant Yukio Sonoda, MD Associate Attending Surgeon Gynecology Service Department of Surgery Memorial Sloan-Kettering Anil K. Sood, MD Judith K. Wolf, MD, MS Pamela A. Weems, BS Program Manager Judi Williams, BS Senior Conference Coordinator CME/Conference Management Saturday, December 3, 2011 Cancer Prevention Building 8th Floor Conference Center 7:00 am Registration and Breakfast 8:00 Abstract and Surgical Film Presentations Moderators: David Huntsman, MD; and Anil K. Sood, MD SESSION V: NOVEL THERAPEUTICS Moderator: Katherine M. Bell-McGuinn, MD, PhD 9:00 PARP Inhibitors in Ovarian Cancer A 2011 Perspective Stan Kaye, MD 9:30 New Directions in Anti-Angiogenesis Therapy Anil K. Sood, MD 10:00 Angiogenesis Inhibitors in Clinical Practice Robert L. Coleman, MD 10:30 Break SESSION VI: CHEMOTHERAPY Moderator: Judith K. Wolf, MD, MS 11:00 Current Chemotherapy for Ovarian Cancer Carol Aghajanian, MD 11:30 Consolidation Therapy in Ovarian Cancer Paul Sabbatini, MD Noon Use of Biomarkers to Personalize Care for Epithelial Ovarian Cancer Robert C. Bast, Jr., MD 12:30 pm Lunch (provided) SESSION VII: NEW CONCEPTS IN OVARIAN CANCER Moderator: Ignace Vergote, MD 1:30 Ovarian Cancer Genomics: Impact on Prevention, Diagnosis, and Recurrence Douglas A. Levine, MD 2:00 Robotics in the Modern Era of Ovarian Cancer Management Ginger J. Gardner, MD 2:30 Video-Assisted Thorascopic Surgery (VATS) in Ovarian Cancer Yukio Sonoda, MD 3:00 pm Closing Remarks and Adjourn Kathleen M. Schmeler MD; and Ginger J. Gardner, MD

5 Faculty Registration Information Robert C. Bast, Jr., MD and Vice President Translational Research Jubilee Brown, MD Associate Eduardo Bruera, MD Palliative Care & Rehabilitation Medicine Robert L. Coleman, MD Molly S. Daniels, MS Genetic Counselor Nicki L. Flowers, RN, MS, WHNP Advanced Practice Nurse Michael Frumovitz, MD, MPH Associate David M. Gershenson, MD and Chair Karen H. Lu, MD Homer A. Macapinlac, MD Nuclear Medicine Pedro T. Ramirez, MD Lois M. Ramondetta, MD Kathleen M. Schmeler, MD Assistant Anil K. Sood, MD Judith K. Wolf, MD, MS Memorial Sloan-Kettering Guest Nadeem Abu-Rustum, MD Director, Minimally Invasive Surgery Carol Aghajanian, MD Chief, Gynecologic Medical Oncology Service Department of Medicine Richard R. Barakat, MD Vice Chair, Clinical Affairs, Department of Surgery Chief, Katherine M. Bell-McGuinn, MD, PhD Assistant Attending Medical Oncologist Gynecology Service, Department of Medicine Dennis S. Chi, MD Deputy Chief, Gynecology Service Director of Gynecology Surgery Fellowship Program Ginger J. Gardner, MD Assistant Attending Surgeon Noah D. Kauff, MD Associate Attending Physician Clinical Genetics Service, Department of Medicine Director, Ovarian Cancer Screening & Prevention Douglas A. Levine, MD Associate Attending Surgeon Gynecologic Service, Department of Surgery Paul Sabbatini, MD Associate Chair for Clinical Trials Gynecologic Medical Oncology Service Department of Medicine Yukio Sonoda, MD Associate Attending Surgeon David Huntsman, MD Associate of Medicine University of British Columbia Genetic Pathologist British Columbia Cancer Agency Vancouver, British Columbia Stan Kaye, MD Head, Drug Development Unit Institute of Cancer Research Head, Section of Medicine Royal Marsden HNS Foundation Trust London, England Ignace Vergote, MD Head, Department of Obstetrics and Gynaecology and Gynaecologic Oncology Catholic University Leuven, Belgium On-site registration and poster set up opens at 7:00 am on Friday, December 2, 2011 in the Conference Center foyer, on the eighth floor of the Cancer Prevention Building, 1155 Pressler, Houston, Texas. Posters may be removed at the close of the conference. The conference will begin at 8:15 am on Friday, December 2, 2011 and adjourn at 3:00 pm on Saturday, December 3, Advance registration is encouraged as space and materials are limited. Please see the registration form for applicable fees. The deadline for advance registration is Friday, November 18, There are three ways to register: Mail the registration form to the Department of CME/Conference Management, Unit 1381, The University of Texas Cancer Center, PO Box , Houston, Texas Fax the registration form to Online at We accept the following forms of payment: Check (payable through US banks only) Money Order Credit Cards (MasterCard, VISA, and American Express) Cash (accepted at on-site registration only) If you register online, a receipt/confirmation letter will be automatically ed to the address provided on the registration form. If you register by fax or mail, a receipt/confirmation letter will be sent to you within ten working days of receipt of your fee. The conference registration fee includes tuition, final program, welcome reception, museum reception, breakfasts, lunches, and breaks. Please refer to the registration form for specific information regarding fees. Refund/Cancellation Policy The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before November 18, No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. Although no refunds will be granted after November 18, 2011, you may transfer your registration to a colleague. For additional information, contact CME/Conference Management at or toll free at The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, , or by the phone or fax numbers provided on the registration form. In case of activity cancellation, the liability of the Department of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee. The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

6 Special Assistance Contact the Department of CME/Conference Management at or toll free at if you have any special dietary or ADA accommodation needs. Accommodations A block of rooms has been reserved for conference attendees at Hotel ZaZa. Early hotel reservation is suggested. The hotel phone number is or toll free at The hotel fax number is When you make reservations, please be sure to mention the International Conference on Ovarian Cancer, to be assured of receiving the meeting rate of $169 single or double occupancy. Please add 17% (Texas) state and local taxes. The deadline to receive the special rate is November 18, 2011, unless the room block has already been filled. Air Travel has a program with Continental Airlines for discounted air travel. For discounts, call your travel professional or Continental s MeetingWorks toll free at Outside of the United States, please call your local Continental Airlines Reservation Office. Mention Z code: ZJMD and Agreement Code: Ground Transportation (prices are subject to change and variable depending on location of conference) Houston is served by two airports, George Bush Intercontinental (IAH) and William P. Hobby (HOU). Taxicabs are available at an estimated cost of $50-$60 to or from William P. Hobby Airport or George Bush Intercontinental Airport. SuperShuttle operates a shuttle bus between George Bush Intercontinental Airport and Hotel ZaZa for $27 one-way and $54 round-trip. For more information, call or toll free at , or online at SuperShuttle operates a shuttle bus between William P. Hobby Airport and Hotel ZaZa for $24 one-way and $48 round-trip. For more information, call or toll-free at , or online at The University of Texas Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity. Agendas are subject to change because we are always striving to improve the quality of your educational experience. may substitute faculty with comparable expertise on rare occasions necessitated by illness, scheduling conflicts, and so forth. Cameras (including cell phone cameras), audio taping and videotaping are prohibited. Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or this material to CME/Conference Management. All responses will be forwarded to the Program Chairs for consideration. THIS IS NOT A SELF-MAILER - Address to: 9th International Conference on Ovarian Cancer Department of CME/Conference Management Unit 1381 The University of Texas Cancer Center PO Box , Houston, TX or fax to Make check or money order payable to: The University of Texas Cancer Center CONFERENCE REGISTRATION th International Conference on Ovarian Cancer December 2-3, 2011 Last Name First MI Highest Degree Department (include box no.) Specialty Institution REGISTRATION FEES Street City State/Foreign Country/Zip or Mail Code Physicians 1 Postmarked before Nov. 18, $ Postmarked after Nov. 18, $ Residents/Fellows/Trainees 1 Postmarked before Nov. 18, $ Postmarked after Nov. 18, $ Nurses 1 Postmarked before Nov. 18, $ Postmarked after Nov. 18, $ One Day 1 Friday... $ Saturday... $ /MSKCC Faculty 1 Postmarked before Nov. 18, $ Postmarked after Nov. 18, $ Daytime Phone (with area code) Cell Phone (with area code) Fax (with area code) Address Emergency Contact Phone (with area code) Charge the following: ovisa omastercard oamerican Express Credit Card Holder Name (First/Last) Credit Card Holder Billing Address & ZIP Code Credit Card Number or Interdepartmental Transfer (IDT) No. Expiration Date Authorized Signature REQUIRED for credit card or IDT Employee ID No. (REQUIRED) IDT Approver Name (First/Last) please print IDT Approver

7 Department of CME/Conference Management - Unit 1381 The University of Texas Cancer Center # / PO Box Houston, TX Non-Profit Org. U.S. Postage P A I D Houston, TX Permit No. 7052